Showing results (61-70 of 69) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 69 results.
Transplantation|January 9, 2023
Immune Response to COVID-19 mRNA Vaccination in Previous Nonresponder Kidney Transplant Recipients After Short-term Withdrawal of Mycophenolic Acid 1 and 3 Months After an Additional Vaccine DoseTessa Kühn, Claudius Speer, Christian Morath, et al.
Clinical Journal of the American Society of Nephrology : CJASN|December 23, 2021
Neutralization of SARS-CoV-2 Variants of Concern in Kidney Transplant Recipients after Standard COVID-19 VaccinationLouise Benning, Christian Morath, Marie Bartenschlager, et al.
JCI Insight|April 10, 2023
suPAR links a dysregulated immune response to tissue inflammation and sepsis-induced acute kidney injuryChristian Nusshag, Changli Wei, Eunsil Hahm, et al.
Clinical and Experimental Rheumatology|April 29, 2024
The Joint Vasculitis Registry in German-speaking countries (GeVas): subgroup analysis of 195 GCA patientsPia Wallmeier, Sabrina Arnold, Arlette Tais, et al.
Clinical and Experimental Rheumatology|April 12, 2024
The Joint Vasculitis Registry in German-speaking countries (GeVas): subgroup analysis of 266 AAV patientsSabrina Arnold, Pia Wallmeier, Arlette Tais, et al.
The Journal of Clinical Investigation|January 29, 2020
Phase I trial of donor-derived modified immune cell infusion in kidney transplantationChristian Morath, Anita Schmitt, Christian Kleist, et al.
Journal of the American Society of Nephrology : JASN|September 22, 2022
Induction of Long-Lasting Regulatory B Lymphocytes by Modified Immune Cells in Kidney Transplant RecipientsChristian Morath, Matthias Schaier, Eman Ibrahim, et al.
BMJ Open|November 11, 2022
Individualised immunosuppression with intravenously administered donor-derived modified immune cells compared with standard of care in living donor kidney transplantation (TOL-2 Study): protocol for a multicentre, open-label, phase II, randomised controlled trialChristian Morath, Anita Schmitt, Michael Schmitt, et al.
Frontiers in Immunology|July 24, 2023
Five-year follow-up of a phase I trial of donor-derived modified immune cell infusion in kidney transplantationMatthias Schaier, Christian Morath, Lei Wang, et al.
Pageof 7